CD8A and B-cell chronic lymphocytic leukemia: In some studies, these reactivations correlated with shorter time-to-first-treatment and reduced overall survival.12–17 The increased frequency of EBV reactivations may indicate a decreased function of EBV-specific CD8+ T cells in CLL patients.